SCHEMBL21177196

SCHEMBL21177196

CNC(=O)c1cc(Br)cc(C2CCOCC2)c1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KAT2B Q92831 1/20 0.42
▸ BAZ2B Q9UIF8 1/20 0.42
▸ FAAH O00519 1/20 0.40
▸ CNR2 P34972 1/20 0.40
▸ DRD3 P35462 3/20 0.38
▸ DRD2 P14416 2/20 0.38
▸ GCK P35557 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ MEN1 O00255 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ OPRK1 P41145 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ MMP1 P03956 1/20 0.36
▸ MMP9 P14780 1/20 0.36
▸ MMP13 P45452 1/20 0.36
▸ ADAM17 P78536 1/20 0.36
▸ BRD4 O60885 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6270454 0.72 FAAH (0.59) FAAHCNR2DRD3DRD2HSD17B10
SCHEMBL30040362 0.71 OPRK1 (0.46) CNR2HSD17B10KMT2AOPRK1
SCHEMBL22820372 0.71 OPRK1 (0.46) CNR2HSD17B10KMT2AOPRK1
SCHEMBL23243125 0.68 WDR5 (0.45) KDM4EMEN1MAPTKMT2AOPRK1
SCHEMBL24683590 0.68 OPRK1 (0.46) KDM4EHSD17B10OPRK1
SCHEMBL22820451 0.66 MAOA (0.42) CNR2KDM4EMEN1MAPTKMT2A
SCHEMBL24252867 0.66 APLNR (0.34) MEN1MAPTKMT2AMAPK1ADAM17
SCHEMBL18512332 0.66 HSD17B10 (0.41) FAAHCNR2KDM4EHSD17B10PKM
SCHEMBL19657313 0.65 CREBBP (0.49) KAT2BBAZ2BCNR2MAPK1BRD4
SCHEMBL30810295 0.65 KDM4E (0.38) DRD2GCKKDM4EHSD17B10OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3740489-A1 PI4KIIIBETA INHIBITORS GlaxoSmithKline Intellectual Property Development Limited (GB) 2020-11-25 — — EP disclosed
WO-2019141694-A1 PI4KIIIBETA INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2019-07-25 — — WO disclosed
Send feedback